Molecular Target Approaches in Head and Neck Cancer: Epidermal Growth Factor Receptor and Beyond-Reference-Cited by-同舟云学术

Molecular Target Approaches in Head and Neck Cancer: Epidermal Growth Factor Receptor and Beyond

Published:2009-01 Issue:1 Volume:19 Page:63-68
ISSN:1053-4296
Container-title:Seminars in Radiation Oncology
language:en
Short-container-title:Seminars in Radiation Oncology

Author:

Harari Paul M.,Wheeler Deric L.,Grandis Jennifer R.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Reference62 articles.

1. Downmodulation of TGF-alpha protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells;Grandis;J Cell Biochem,1998

2. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells;Grandis;Oncogene,1997

3. Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma;Grandis;Clin Cancer Res,1998

4. Signaling through the epidermal growth factor receptor during the development of malignancy;Grandis;Pharmacol Ther,2004

5. Epidermal growth factor receptor–targeted molecular therapeutics for head and neck squamous cell carcinoma;Egloff;Expert Opin Ther Targets,2006

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review;Frontiers in Oncology;2024-08-22

2. Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit;Cancers;2024-01-11

3. A Focused Review of the Pharmacological Potentials of Terrein as an Anticancer Agent;Natural Product Communications;2023-05

4. Targeted therapy for head and neck cancer: signaling pathways and clinical studies;Signal Transduction and Targeted Therapy;2023-01-16

5. Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression;Journal of Biological Chemistry;2022-06